Trading Options with an Edge
Select Page

TRIL

Search by
TICKER SYMBOL

Trillium Therapeutics Inc

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

17.81

0.08

(0.451%)

Volume:

1,049,891

52 week range:

5.8 - 20.96

Market Cap:

1.867B

Company Description:

Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s two clinical programs, TTI-621 and TTI-622, target CD47, a “don’t eat me” signal that cancer cells frequently use to evade the immune system.